Despite a tiny domestic market size, the Lithuanian life sciences sector is full of hidden surprises. Comprising four percent of the nation’s entire GDP, with one percent accounted for by a burgeoning biotechnology sector, Lithuania can draw on a strong science R&D infrastructure and a talented domestic labor pool.

The multinational affiliate leaders, heads of significant local players, key opinion leaders, government officials, and regulators featured in this report unpack these topics, along with a range of others including the country’s outstanding potential in clinical trials, the possibilities of acting as a biotech hub for the Baltics, and how companies are drawing on Lithuania’s heritage as one of the world’s leading manufacturers of lasers.